An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases
-
Silvia Lorente-Cebrián [1] ; André G. V. Costa [1] ; Santiago Navas-Carretero [1] ; María Zabala [1] ; Laura M. Laiglesia [1] ; J. Alfredo Martínez [1] ; María J. Moreno-Aliaga [1]
-
[1] Universidad de Navarra
Universidad de Navarra
Pamplona, España
-
- Localización: Journal of physiology and biochemistry, ISSN-e 1877-8755, ISSN 1138-7548, Vol. 71, Nº. 2 (June), 2015, págs. 341-349
- Idioma: inglés
- Enlaces
- Dialnet Métricas: 3 Citas
-
Resumen
Inflammation is involved in the pathophysiology of many chronic diseases, such as rheumatoid arthritis and neurodegenerative diseases. Several studies have evidenced important anti-inflammatory and immunomodulatory properties of omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs). This review illustrates current knowledge about the efficacy of n-3 LC-PUFAs (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), particularly) in preventing and/or treating several chronic inflammatory conditions (inflammatory bowel diseases and rheumatoid arthritis) as well as their potential benefits on neurodegenerative diseases. It is well established that n-3 LC-PUFAs are substrates for synthesis of novel series of lipid mediators (e.g., resolvins, protectins, and maresins) with potent anti-inflammatory and pro-resolving properties, which have been proposed to partly mediate the protective and beneficial actions of n-3 LC-PUFAs. Here, we briefly summarize current knowledge from preclinical studies analyzing the actions of EPA- and DHA-derived resolvins and protectins on pathophysiological models of rheumatoid arthritis, Alzheimer, and irritable bowel syndrome.
